Skip to content
10-Q

Quarterly Report

TIVITY HEALTH, INC.

0001564590-21-054785

← back to feed
Filed
Nov 5, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 2, 2021 49.75M sh
Shares Diluted Q3 2021 · Sep 30, 2021 50.36M sh
Shares Diluted Q3 2021 · Sep 30, 2021 50.4M sh
Shares Diluted restated Q3 2021 · Sep 30, 2020 49.4M sh
Shares Diluted restated Q3 2021 · Sep 30, 2020 49.02M sh
Capex Q3 2021 · Sep 30, 2021 $6.65M
Capex Q3 2021 · Sep 30, 2020 $13.27M
Operating Cash Flow Q3 2021 · Sep 30, 2021 $65.22M
Operating Cash Flow Q3 2021 · Sep 30, 2020 $164.95M
Long Term Debt Q3 2021 · Sep 30, 2021 $381.05M
Long Term Debt Q3 2021 · Dec 31, 2020 $459.25M
Short Term Investments Q3 2021 · Sep 30, 2021 $91.18M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $51.76M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $100.39M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $56.44M
Cash And Equivalents Q3 2021 · Dec 31, 2019 $2.49M
Stockholders Equity Q3 2021 · Sep 30, 2021 $140.67M
Stockholders Equity Q3 2021 · Jun 30, 2021 $34.79M
Stockholders Equity Q3 2021 · Dec 31, 2020 $3.66M
Stockholders Equity restated Q3 2021 · Sep 30, 2020 −$969K
Stockholders Equity restated Q3 2021 · Jun 30, 2020 $34.51M
Stockholders Equity restated Q3 2021 · Dec 31, 2019 $223.7M
Current Liabilities Q3 2021 · Sep 30, 2021 $92.83M
Current Liabilities Q3 2021 · Dec 31, 2020 $81.84M
Current Assets Q3 2021 · Sep 30, 2021 $229.29M
Current Assets Q3 2021 · Dec 31, 2020 $154.25M
Total Assets Q3 2021 · Sep 30, 2021 $631.44M
Total Assets Q3 2021 · Dec 31, 2020 $578.98M
Eps Diluted Q3 2021 · Sep 30, 2021 $2.04
Eps Diluted Q3 2021 · Sep 30, 2021 $2.58
Eps Diluted restated Q3 2021 · Sep 30, 2020 −$0.86
Eps Diluted restated Q3 2021 · Sep 30, 2020 −$4.33
Eps Basic Q3 2021 · Sep 30, 2021 $2.07
Eps Basic Q3 2021 · Sep 30, 2021 $2.63
Eps Basic Q3 2021 · Sep 30, 2020 −$0.87
Eps Basic Q3 2021 · Sep 30, 2020 −$4.35
Sga Expense Q3 2021 · Sep 30, 2021 $10.64M
Sga Expense Q3 2021 · Sep 30, 2021 $29.99M
Sga Expense restated Q3 2021 · Sep 30, 2020 $9.69M
Sga Expense restated Q3 2021 · Sep 30, 2020 $30.65M
Net Income Q3 2021 · Sep 30, 2021 $102.77M
Net Income Q3 2021 · Sep 30, 2021 $130.26M
Net Income Q3 2021 · Sep 30, 2020 −$42.42M
Net Income Q3 2021 · Sep 30, 2020 −$212.01M
Operating Income Q3 2021 · Sep 30, 2021 $37.03M
Operating Income Q3 2021 · Sep 30, 2021 $111.86M
Operating Income restated Q3 2021 · Sep 30, 2020 $33.5M
Operating Income restated Q3 2021 · Sep 30, 2020 $91.39M
Revenue Q3 2021 · Sep 30, 2021 $126.29M
Revenue Q3 2021 · Sep 30, 2021 $354.44M
Revenue restated Q3 2021 · Sep 30, 2020 $95.48M
Revenue restated Q3 2021 · Sep 30, 2020 $337.1M